Last $14.56 USD
Change Today +0.13 / 0.90%
Volume 206.8K
EBS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Fuad El-Hibri

Founder, Executive Chairman and Chairman of Strategic Operations Committee, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 114 board members in 3 different organizations across 3 different industries.

See Board Relationships
54$1,408,428
As of Fiscal Year 2012

Background*

Mr. Fuad El-Hibri has been the Chairman of the Board and Chief Executive Officer of Emergent Biodefense Operations Lansing Inc., a subsidiary of Emergent Biosolutions Inc. since June 2004. Mr. El-Hibri founded Emergent Biosolutions Inc. in 2004 and has been its Executive Chairman since June 2004. He served as Chief Executive Officer of Emergent Biosolutions Inc from June 2004 to April 01, 2012. He served as the President of Emergent BioSolutions, Inc. from March 2006 ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

Former Chairman
Director
Chairman and Chief Executive Officer
2004-Present
Founder, Executive Chairman and Chairman of Strategic Operations Committee

Education*

BA
Stanford University
Master's Degree
Yale University

Other Affiliations*

Annual Compensation*

Salary$726,228
Bonus$159,515
Total Annual Compensation$885,743

Stock Options*

Restricted Stock Awards$253,929
All Other Compensation$63,862
Exercisable Options224,379
Exercisable Options Value$308,662
Unexercisable Options113,780
Unexercisable Options Value$10,403
Total Value of Options$319,065
Total Number of Options338,159

Total Compensation*

Total Annual Cash Compensation$949,605
Total Short Term Compensation$885,743
Other Long Term Compensation$317,791
Total Calculated Compensation$1,408,428
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $14.56 USD +0.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. Kishbauch Chief Executive Officer, President and Director
Achillion Pharmaceuticals, Inc.
$470.3K
Cynthia L. Sullivan Chief Executive Officer, President, Director and President of IBC Pharmaceuticals Inc
Immunomedics Inc.
$580.6K
Eric A. Rose M.D.Executive Chairman, Chief Executive Officer and Member of National Biodefense Science Board
SIGA Technologies, Inc.
$1.1M
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee
Spectrum Pharmaceuticals, Inc.
$2.4M
Anders Hedegaard MScChief Executive Officer and President
Bavarian Nordic A/S
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.